lawsuit compounded semaglutide FDA faces new from compounders over wight loss drugs Novo Nordisk expands legal action
Description
A 0.25 mg dose is 0.1 mL, which equals 10 units on a U-100 syringe
Patients whose joint pain limits the exercise capacity needed to lose weight through lifestyle intervention alone a genuinely vicious cycle benefit particularly from a pharmacologic approach that produces meaningful loss independent of exercise capacity
Some health problems make it dangerous or downright unsafe
Patients may take semaglutide with B12 or B6, depending on their preference
But its also likely that people quit because the drugs are expensive, or theyve not lost enough weight
